WASHINGTON (MedPage Today) — The Senate voted down two drug importation amendments to the healthcare reform bill on Tuesday night in a complex procedural maneuver that highlighted the sometimes not-so-subtle pull the pharmaceutical industry has in Congress.
No Comments »
Filed under: General Health News
Sanofi Pasteur has recalled about 800,000 doses of its vaccine against pandemic H1N1 influenza because of low potency, the CDC announced.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — The FDA opened its Mexico City post, the agency’s third office in Latin America and tenth international post created in just over a year.
No Comments »
Filed under: General Health News
Although states have made substantial progress in preparing for public health emergencies in recent years, the H1N1 pandemic has revealed remaining deficiencies, according to a new report.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — The Senate voted down two drug importation amendments to the healthcare reform bill on Tuesday night in a complex procedural maneuver that highlighted the sometimes not-so-subtle pull the pharmaceutical industry has in Congress.
No Comments »
Filed under: Pharmacy News
Nanotherapeutics, Inc., a privately held biopharmaceutical company, announced that it has acquired in bankruptcy proceedings two late stage clinical programs: Ramoplanin from Oscient Pharmaceuticals Corporation and PRX-3140 from EPIX Pharmaceuticals, Inc.
No Comments »
Filed under: Pharmacy News
ChemoCentryx, Inc. today announced that it has begun enrolling patients in a Phase 2 clinical trial of CCX354, an orally-bioavailable, novel, small molecule drug designed to specifically target the CCR1 chemokine receptor for the treatment of rheumatoid arthritis (RA).
No Comments »
Filed under: Pharmacy News
Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS), today announced positive top-line results from a pivotal, non-human primate study of its novel, once-a-day, oral antibiotic Restanza(TM) (cethromycin) against an inhaled lethal dose of tularemia. A 14-day course of Restanza achieved a 100% survival rate at the doses tested. All of the ten animals in [...]
No Comments »
Filed under: Pharmacy News
Æterna Zentaris Inc., a global biopharmaceutical company focused on oncology and endocrine therapy, today announced the initiation, by its partner Keryx Biopharmaceuticals Inc., of a Phase 3 registration clinical trial for perifosine (KRX-0401), the Company’s PI3K/Akt pathway inhibitor, in relapsed/refractory multiple myeloma patients.
No Comments »
Filed under: Pharmacy News
Onset Therapeutics, a specialty pharmaceutical company focused in dermatology, today announced positive results from a skin moisturization study that compared the Company’s recently launched BenzEFoam™ (benzoyl peroxide 5.3%) Emollient Foam to a market leading combination gel containing clindamycin 1% - benzoyl peroxide 5%. BenzEFoam™ Emollient Foam is indicated for the topical treatment of mild to [...]
No Comments »
Filed under: Pharmacy News
